TNF-α and microalbuminuria in patients with type 2 diabetes mellitus

I-Th Lampropoulou1, M Stangou1, A Papagianni1

  • 1Department of Nephrology, "Hippokratio" General Hospital, Aristotle University of Thessaloniki, 49 Konstantinoupoleos Street, 546 42 Thessaloniki, Greece.

Abstract

Insights

In type 2 diabetes, urinary tumor necrosis factor-alpha (TNF-α) levels correlate with microalbuminuria, a marker of kidney damage. Serum TNF-α levels did not show this association, highlighting urinary TNF-α as a potential indicator.

Area of Science:

  • Nephrology
  • Endocrinology
  • Immunology

Background:

  • Chronic subclinical inflammation is implicated in diabetic nephropathy development.
  • Microalbuminuria is an early indicator of kidney damage in diabetes.

Purpose of the Study:

  • To explore the relationship between microalbuminuria and inflammation markers in type 2 diabetes mellitus.
  • To determine if serum or urinary tumor necrosis factor-alpha (TNF-α) correlates with microalbuminuria.

Main Methods:

  • Eighty patients with type 2 diabetes were analyzed.
  • Urinary albumin-creatinine ratio (ACR) and serum/urinary TNF-α levels were measured.
  • Clinical data including HbA1c, complications, and medications were recorded.

Main Results:

  • Microalbuminuria was associated with older age, higher HbA1c, and more comorbidities.
  • Albumin-creatinine ratio (ACR) correlated with cardiovascular disease, hypertension, HbA1c, and certain medications.
  • Urinary TNF-α showed a strong correlation with ACR, while serum TNF-α did not.

Conclusions:

  • Urinary TNF-α levels are linked to the presence and severity of microalbuminuria in type 2 diabetes.
  • Serum TNF-α levels are not associated with microalbuminuria in this patient cohort.
  • Urinary TNF-α may serve as a valuable biomarker for diabetic kidney disease progression.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
2
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
378
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
4
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
1
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
8